[1] I. Dardick, “Hibernoma: A Possible Model of Brown Fat Histogenesis,” Human Pathology, Vol. 9, No. 3, 1978, pp. 321-319. doi:10.1016/S0046-8177(78)80089-6
[2] H. Sell, Y. Deshaies and D. Richard, “The Brown Adipocyte: Update on Its Metabolic Role,” The International Journal of Biochemistry & Cell Biology, Vol. 36, No. 11, 2004, pp. 2098-2104. doi:10.1016/j.biocel.2004.04.003
[3] S. Robison, A. Rapmund, C. Hemmings, M. Fulham and P. Barry, “False-Positive Diagnosis of Metastasis on Positron Emission Tomography-Computed Tomography Imaging Due to Hibernoma,” Journal of Clinical Oncology, Vol. 27, No. 6, 2009, pp. 994-995. doi:10.1200/JCO.2008.19.4977
[4] M. A. Furlong, J. C. Fanburg-Smith and M. Miettinen, “The Morphologic Spectrum of Hibernoma: A Clinicopathologic Study of 170 Cases,” The American Journal of Surgical Pathology, Vol. 25, No. 6, 2001, pp. 809-814. doi:10.1097/00000478-200106000-00014
[5] P. S. Gerard, H. Finestone, R. Lazzaro and M. D. Geller, “Intermittent FDG Uptake in Lipomatous Hypertrophy of the Interatrial Septum on Serial PET/CT Scans,” Clinical Nuclear Medicine, Vol. 33, No. 9, 2008, pp. 602-605. doi:10.1097/RLU.0b013e318181312a
[6] Y. Zafar and A. R. Jazieh, “Lipomatous Hypertrophy of the Interatrial Septum Evidenced on Positron Emission Tomography in a Patient with Thyroid Cancer,” American Journal of Clinical Oncology, Vol. 29, No. 4, 2006, pp. 418-419. doi:10.1097/01.coc.0000170585.91248.b8
[7] C. M. Fan, A. J. Fischman, B. H. Kwek, S. Abbara and S. L. Aquino, “Lipomatous Hypertrophy of the Interatrial Septum: Increased Uptake on FDG PET,” American Journal of Roentgenology, Vol. 184, No. 1, 2005, pp. 339-342. doi:10.2214/ajr.184.1.01840339
[8] N. Martini, et al. “An Unusual Breast Lesion: The Ultrasonographic, Mammographic, MRI and Nuclear Medicine Findings of Mammary Hibernoma,” British Journal of Radiology, Vol. 83, No. 985, 2010, pp. 1-4. doi:10.1259/bjr/17929543
[9] J. Nishida, et al. “Clinical Findings of Hibernoma of the Buttock and Thigh: Rare Involvements and Extremely High Uptake of FDG-PET,” Medical Science Monitor, Vol. 15, No. 7, 2009, pp. CS117-CS122.
[10] T. Tsuchiya, T. Osanai, A. Ishikawa, N. Kato, Y. Watanabe and T. Ogino, “Hibernomas Show Intense Accumulation of FDG Positron Emission Tomography,” Journal of Computer Assisted Tomography, Vol. 30, No. 2, 2006, pp. 333-336. doi:10.1097/00004728-200603000-00033
[11] R. Suzuki, et al. “PET Evaluation of Fatty Tumors in the Extremity: Possibility of Using the Standardized Uptake Value (SUV) to Differentiate Benign Tumors from Liposarcoma,” Annals of Nuclear Medicine, Vol. 19, No. 8, 2005, pp. 661-670. doi:10.1007/BF02985114
[12] C. S. Smith, J. Teruya-Feldstein, J. F. Caravelli and H. W. Yeung, “False-Positive Findings on 18F-FDG PET/CT: Differentiation of Hibernoma and Malignant Fatty Tumor on the Basis of Fluctuating Standardized Uptake Values,” American Journal of Roentgenology, Vol. 190, No. 4, 2008, pp. 1091-1096. doi:10.2214/AJR.07.3061
[13] M. J. Burdick, P. R. Jolles, M. M. Grimes and D. A. Henry, “Mediastinal Hibernoma Simulates a Malignant Lesion on Dual Time Point FDG Imaging,” Lung Cancer, Vol. 59, No. 3, 2008, pp. 391-394. doi:10.1016/j.lungcan.2007.08.020
[14] L. W. Bancroft, M. J. Kransdorf, J. J. Peterson and M. I. O’Connor, “Benign Fatty Tumors: Classification, Clinical Course, Imaging Appearance, and Treatment,” Skeletal Radiology, Vol. 35, No. 10, 2006, pp. 719-733. doi:10.1007/s00256-006-0189-y
[15] C. M. Park, J. M. Goo, H. J. Lee, M. A. Kim, C. H. Lee and M. J. Kang, “Tumors in the Tracheobronchial Tree: CT and FDG PET Features,” RadioGraphics, Vol. 29, No. 1, 2009, pp. 55-71. doi:10.1148/rg.291085126